Legal & General Group Portfolio holdings
Legal & General Group Plc, founded in 1836 by six lawyers in London, is a British multinational financial services company headquartered in London, renowned for its leadership in insurance, pensions, and investment management. Managing trillions in assets, the firm operates through key divisions like Legal & General Investment Management (LGIM), one of the UK’s largest asset managers, focusing on index funds, active strategies, and sustainable investing for institutional clients like pension funds. It also provides life insurance, retirement products, and general insurance, serving millions of customers with a strong emphasis on long-term financial security and infrastructure investment, such as affordable housing. With a heritage of stability and a modern push toward ESG (environmental, social, governance) principles, Legal & General remains a cornerstone of the UK financial landscape with a growing global presence.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$4.96B |
| 2 |
SUNB
Sunbelt Rentals Holdings
SUNB
|
+$201M |
| 3 |
Palo Alto Networks
PANW
|
+$141M |
| 4 |
Johnson & Johnson
JNJ
|
+$141M |
| 5 |
Rayonier
RYN
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$605M |
| 2 |
Broadcom
AVGO
|
+$425M |
| 3 |
NVIDIA
NVDA
|
+$412M |
| 4 |
Microsoft
MSFT
|
+$347M |
| 5 |
CYBR
CyberArk
CYBR
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.6% |
| 2 | Financials | 12.66% |
| 3 | Healthcare | 10.78% |
| 4 | Communication Services | 9.19% |
| 5 | Consumer Discretionary | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2201
British American Tobacco
BTI
$132B
| $830K | ﹤0.01% |
14,192
-32,772
| -70% | -$1.94M |
|
2202
PACS Group
PACS
$7.42B
| $827K | ﹤0.01% |
25,753
-7,460
| -22% | -$274K |
|
2203
Revolve Group
RVLV
$1.79B
| $824K | ﹤0.01% |
36,448
-5,510
| -13% | -$145K |
|
2204
Kosmos Energy
KOS
$1.56B
| $818K | ﹤0.01% |
294,581
-117,069
| -28% | -$220K |
|
2205
Relay Therapeutics
RLAY
$4.02B
| $816K | ﹤0.01% |
82,056
-27,152
| -25% | -$243K |
|
2206
Biohaven
BHVN
$2.16B
| $812K | ﹤0.01% |
95,987
-17,439
| -15% | -$191K |
|
2207
Community Trust Bancorp
CTBI
$1.38B
| $810K | ﹤0.01% |
13,335
-2,283
| -15% | -$139K |
|
2208
N-able
NABL
$769M
| $809K | ﹤0.01% |
173,195
-19,156
| -10% | -$107K |
|
2209
Old Second Bancorp
OSBC
$1.24B
| $809K | ﹤0.01% |
40,107
-10,517
| -21% | -$211K |
|
|
TIC
2210
TIC Solutions Inc
TIC
$1.58B
| $807K | ﹤0.01% |
122,717
-26,959
| -18% | -$254K |
|
2211
F&G Annuities & Life
FG
$3.93B
| $800K | ﹤0.01% |
31,579
-70,582
| -69% | -$1.84M |
|
2212
Cytek Biosciences
CTKB
$576M
| $799K | ﹤0.01% |
182,860
-5,608
| -3% | -$26.5K |
|
2213
Douglas Dynamics
PLOW
$1.07B
| $794K | ﹤0.01% |
18,874
-3,650
| -16% | -$147K |
|
2214
SkyWater Technology
SKYT
$1.51B
| $794K | ﹤0.01% |
28,966
+2,868
| +11% | +$84.3K |
|
|
USAS
2215
Americas Gold and Silver
USAS
$1.34B
| $786K | ﹤0.01% |
150,996
-59,015
| -28% | -$431K |
|
2216
Appian
APPN
$1.74B
| $781K | ﹤0.01% |
32,385
-7,343
| -18% | -$199K |
|
|
ORKA
2217
Oruka Therapeutics
ORKA
$5.56B
| $781K | ﹤0.01% |
15,918
-2,826
| -15% | -$98.2K |
|
|
NPKI
2218
NPK International
NPKI
$1.21B
| $779K | ﹤0.01% |
53,793
-23,112
| -30% | -$321K |
|
2219
iShares MSCI India Small-Cap ETF
SMIN
$722M
| $779K | ﹤0.01% |
13,450
| – | – |
|
|
BBUC
2220
Brookfield Business Corp Class A Subordinate Voting Shares
BBUC
$6.42B
| $778K | ﹤0.01% |
24,718
-140
| -0.6% | -$4.81K |
|
2221
Amylyx Pharmaceuticals
AMLX
$2.05B
| $775K | ﹤0.01% |
55,773
-16,839
| -23% | -$237K |
|
2222
Byline Bancorp
BY
$1.75B
| $774K | ﹤0.01% |
24,532
-6,096
| -20% | -$191K |
|
2223
Origin Bancorp
OBK
$1.66B
| $774K | ﹤0.01% |
18,698
-10,901
| -37% | -$454K |
|
2224
Takeda Pharmaceutical
TAK
$55.1B
| $774K | ﹤0.01% |
43,464
-64,382
| -60% | -$1.13M |
|
2225
Iovance Biotherapeutics
IOVA
$2.23B
| $773K | ﹤0.01% |
220,161
-38,515
| -15% | -$123K |
|
Similar funds
Legal & General Group's Q1 2026 Portfolio in Review
As of Q1 2026, Legal & General Group held 3,422 positions worth $432B, down 4.1% from $451B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Trading was light in Q1 2026: portfolio turnover was 2.7%. Legal & General Group opened 34 new positions and exited 60, leaving the 3,422-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.
- Legal & General Group's largest Q1 2026 buy was Sunbelt Rentals Holdings: 2,857,761 shares worth $179M.
- Legal & General Group added most to AstraZeneca in Q1 2026, an estimated $4.96B increase.
- Legal & General Group's biggest Q1 2026 reduction was Apple, cutting an estimated $605M.
- Legal & General Group fully exited CyberArk in Q1 2026, selling an estimated $238M.
- Legal & General Group's ten largest holdings make up 32% of its $432B portfolio in Q1 2026.
- Legal & General Group opened 34 new positions and closed 60 in Q1 2026.
- Legal & General Group's portfolio value fell 4.1% quarter-over-quarter to $432B.
Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.